Getting better, still room for growth but better then big pharma - Recensione dipendente - Research Associate III presso Regeneron

4,0
28 dic 2011
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Job security relatively safe which is a nice change from the constant lay offs at big pharma. Compensation is improving with the recent drug approval. Laid back atmosphere, lots of parties (although the ones on site now have 2 beer max, again not horrible). Overall everyone seems to be happy

Svantaggi

Biggest complain is compensation and fairness in performance evaluations. If they improve this I think overall morale will be higher. Also a clear path in terms what is expected to grow/get promoted would be nice

Esplora altre recensioni su Regeneron

5,0
13 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

exciting work and you learn a lot

Svantaggi

You work a lot, but the politics is probably the main issue

3,0
22 giu 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good pay and benefits. Flexibility of work hours.

Svantaggi

If you're in the wrong group, it's a struggle to get autonomy even when you ask for more oversight of a group or project because micromanaging is an issue. I feel trapped where I am and growth has been stagnant. They also hold a mistake against you for years. Management afraid to give constructive criticism.

Vedi recensioni per: Utile|Valutazione|Data|Tutto